Koninklijke Philips | PHG - Current Assets


Koninklijke Philips reported EUR9.78B in Current Assets for its fiscal quarter ending in March of 2026.





Current Assets Change Date
Abbott USD 25.51B 488M Mar/2026
Baxter International USD 6.85B 25M Mar/2026
Becton, Dickinson and Co. USD 8.01B 1.18B Mar/2026
Boston Scientific USD 8.68B 110M Mar/2026
Danaher USD 13.94B 1.18B Mar/2026
Demant DKK 10.08B 128M Dec/2025
Dexcom USD 4.33B 298.4M Mar/2026
Edwards Lifesciences USD 6.23B 510.2M Mar/2026
Fresenius EUR 11.03B 1.03B Dec/2025
General Electric Aerospace USD 39.7B 664M Jun/2026
Getinge SEK 15.77B 2.39B Jun/2026
Globus Medical USD 2.2B 72.51M Mar/2026
GN Store Nord DKK 4.85B 3.79B Mar/2026
Hitachi JPY 7.87T 314.77B Mar/2026
Idexx Laboratories USD 1.45B 40.25M Mar/2026
Insulet USD 1.71B 204.5M Mar/2026
Integra LifeSciences USD 1.17B 12.47M Mar/2026
Intuitive Surgical USD 12.33B 807.5M Jun/2026
J&J USD 59.17B 3.55B Mar/2026
Koninklijke Philips EUR 9.78B 1.88B Mar/2026
Medtronic USD 24.07B 75M Dec/2025
Philips EUR 9.78B 148M Mar/2026
ResMed USD 4.06B 245.26M Mar/2026
Smith & Nephew USD 4.63B 169M Dec/2025
Steris USD 2.39B 108.4M Mar/2026
Stryker USD 13.34B 1.42B Mar/2026
Teleflex USD 1.86B 78.67M Mar/2026
Terumo JPY 861.04B 45.48B Mar/2026
Zimmer Biomet Holdings USD 4.96B 157.4M Mar/2026